Epigenetics and human disease

Nature Medicine

Volumn 2, Issue 3, 1996, Pages 281-282

  Issa, Jean Pierre J ^a   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

BODY GROWTH; GENE LOCUS; GENETIC DISORDER; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; X CHROMOSOME;

ADULT; ALLELES; CHILD; DOSAGE COMPENSATION, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MUSCLE PROTEINS; PHENOTYPE; RNA, UNTRANSLATED;

EID: 0029920785     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0396-281     Document Type: Short Survey

References (18)

1. Morison, I.M., Becroft, D.M., Taniguchi, T., Woods, C.G. & Reeve, A.E. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med. 2, 311-316 (1996).
2. Rastan, S. X chromosome inactivation and the Xist gene. Curr. Opin. Genet. Dev. 4, 292-297 (1994).
3. Barlow, D.P. Gametic imprinting in mammals. Science 270, 1610-1613 (1995).
4. Elliott, M. & Maher, E.R. Beckwith-Wiedemann syndrome. J. Med. Genet. 31, 560-564 (1994).
5. Weksberg, R., Shen, D.R., Fei, Y.L., Song, Q.L & Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5, 143-150 (1993).
6. Ogawa, O. et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749-751 (1993).
7. Rainier, S. et al. Relaxation of imprinted genes in human cancer. Nature 362, 747-749 (1993).
8. Leisenring, W.M. et al. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res. 54, 4680-4683 (1994).
9. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. & Tycko, B. Tumour-suppressor activity of H19 RNA. Nature 365, 764-767 (1993).
10. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genet. 11, 204-206 (1995).
11. Tate, P.H. & Bird, A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226-231 (1993).
12. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
13. Reik, W. et al. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4, 2379-2385 (1995).
14. Fey, M.F. et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood 83, 931-938 (1994).
15. Warren, S.T. & Nelson, D.L. Advances in molecular analysis of fragile X syndrome. JAMA 271, 536-542 (1994).
16. Bulling, K. et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature Genet. 9, 395-400 (1995).
17. Herman, J.G. et al. Inactivation of the CDKN2/p16/MTS1 gene Is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530 (1995).
18. Issa, J.P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536-540 (1994).